First American Bank Has $15.93 Million Stock Holdings in Danaher Corporation (NYSE:DHR)

First American Bank lifted its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 7.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,724 shares of the conglomerate's stock after purchasing an additional 5,157 shares during the period. Danaher accounts for about 1.2% of First American Bank's portfolio, making the stock its 22nd biggest position. First American Bank's holdings in Danaher were worth $15,933,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Canton Hathaway LLC boosted its holdings in Danaher by 22.2% in the first quarter. Canton Hathaway LLC now owns 14,150 shares of the conglomerate's stock worth $2,901,000 after acquiring an additional 2,575 shares in the last quarter. World Equity Group Inc. lifted its holdings in shares of Danaher by 68.5% in the first quarter. World Equity Group Inc. now owns 4,594 shares of the conglomerate's stock valued at $951,000 after purchasing an additional 1,868 shares in the last quarter. Norway Savings Bank lifted its holdings in shares of Danaher by 5.7% in the first quarter. Norway Savings Bank now owns 6,539 shares of the conglomerate's stock valued at $1,340,000 after purchasing an additional 354 shares in the last quarter. GAM Holding AG lifted its holdings in shares of Danaher by 12.6% in the first quarter. GAM Holding AG now owns 14,547 shares of the conglomerate's stock valued at $2,982,000 after purchasing an additional 1,631 shares in the last quarter. Finally, Stonegate Investment Group LLC lifted its holdings in shares of Danaher by 15.1% in the first quarter. Stonegate Investment Group LLC now owns 259,150 shares of the conglomerate's stock valued at $53,126,000 after purchasing an additional 33,951 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on DHR shares. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research report on Monday, April 7th. Wolfe Research decreased their price target on Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a research report on Monday, April 7th. The Goldman Sachs Group decreased their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. Robert W. Baird decreased their price target on Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Finally, Guggenheim restated a "buy" rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $248.17.

Insider Activity

In related news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Danaher Trading Up 0.9%

Shares of DHR stock opened at $196.23 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The business has a 50-day moving average price of $193.89 and a two-hundred day moving average price of $209.69. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $281.70. The firm has a market cap of $140.43 billion, a P/E ratio of 38.10, a price-to-earnings-growth ratio of 2.73 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The firm had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.